MedTrace Logo

Pleurodesis Using Hypertonic Glucose to Treat Post-operative Air Leaks

NCT03905408 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-05-12

No results posted yet for this study

Summary

The investigators will define the most appropriate safe dose of D50 to heal air leaks in patients that have undergone lung resection surgery

Conditions

  • Postoperative Air Leak

Interventions

DRUG

50 mL of 50% Glucose

1st dose

DRUG

100 mL of 50% Glucose

2nd dose

DRUG

150 mL of 50% Glucose

3rd dose

DRUG

200 mL of 50% Glucose

4th dose

Sponsors & Collaborators

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-17
Primary Completion
2021-02-01
Completion
2021-02-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03905408 on ClinicalTrials.gov